**Core Concept**
Thalidomide is a teratogenic drug with immunomodulatory and anti-angiogenic properties. It was previously used as a sedative but is now utilized in the treatment of certain diseases due to its unique mechanism of action.

**Why the Correct Answer is Right**
Thalidomide's immunomodulatory effects are primarily mediated through the inhibition of the production of tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine. This action is critical in the treatment of multiple myeloma, a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow. Thalidomide's anti-angiogenic properties also contribute to its efficacy in treating this condition by inhibiting the formation of new blood vessels that supply the tumor with oxygen and nutrients.

**Why Each Wrong Option is Incorrect**
**Option A:** Thalidomide is not primarily used in the treatment of hypertension. While it does have some effects on the cardiovascular system, this is not its primary indication.
**Option B:** Thalidomide is not used in the treatment of asthma. Its immunomodulatory effects are not beneficial in this condition, and its use could potentially exacerbate asthma symptoms.
**Option C:** Thalidomide is not used in the treatment of diabetes mellitus. Its mechanism of action does not involve the regulation of blood glucose levels.

**Clinical Pearl / High-Yield Fact**
Thalidomide is a classic example of a drug with a unique mechanism of action that has been repurposed for the treatment of a specific disease. Its use in multiple myeloma highlights the importance of understanding the pharmacological properties of a drug and its potential applications in treating various conditions.

**Correct Answer:** D. Multiple myeloma.